Skip to content

Enhanced Recovery in Laparoscopic Cholecystectomy

Modified Enhanced Recovery Program in Patients With Acute Cholecystitis Undergoing Laparoscopic Cholecystectomy: Prospective Randomized Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03754751
Acronym
ERLAC
Enrollment
189
Registered
2018-11-27
Start date
2017-01-31
Completion date
2019-01-30
Last updated
2021-01-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Cholecystitis, Gangrenous Cholecystitis

Keywords

enhanced recovery, intraperitoneal anesthesia, low pressure pneumoperitoneum, cholecystitis, in-hospital stay, laparoscopic cholecystectomy

Brief summary

The study assesses the impact of the modified enhanced recovery protocol on the results of surgical treatment of patients with acute cholecystitis.

Detailed description

Laparoscopic cholecystectomy (LC) is the most common surgical procedures in the world. Elective LC is commonly performed as one-day surgery, while in an emergency setting of acute cholecystitis the in-hospital stay averages 4.5 days. Causes of prolonged rehabilitation period are often associated with severe pain syndrome, dyspepsia and postoperative complications. The complications rate after LC is about 6% and has no tendency to decrease. The implementation of enhanced recovery after surgery (ERAS) programs may potentially reduce stress-associated complications and improve the quality of rehabilitation. A few retrospective studies examined their advantages and setbacks in the treatment of acute cholecystitis with encouraging results. The aim of this randomized control study is to evaluate the modified ERAS program for patients with acute cholecystitis.

Interventions

PROCEDURELaparoscopic cholecystectomy with the implementation of modified ERAS program

Preoperative Crystalloid isotonic solutions and antibiotic prophylaxis 30 min prior to surgery. 1\) Patient informing and brochure Surgery Cholecystectomy using monopolar by experienced surgeons under general anesthesia 1. Low-pressure pneumoperitoneum (8-9 mmHg) 2. Trocar wound and intraabdominal anesthesia with 0.25% ropivacaine 3. PONV prophylaxis in patients of risk Postoperative care 1. Early mobilization (2 h after surgery) 2. Early fluid intake (2 h after surgery) 3. Early liquid food (6 h after surgery) Antibiotics for 3-5 d for patients with complicated cholecystitis (TG13 2). The postoperative pain level evaluation in rest by VAS in 0 h (immediately after awakening), 6 h and 24 h postop. The postoperative analgesic modality on demand: Ketorolac 30 mg for patients with VAS pain level ≥ 5 cm. Antiemetics in dyspepsia. No iv infusions postoperatively. Intestinal peristalsis evaluation by auscultation every 2 h after surgery

PROCEDURELaparoscopic cholecystectomy with standard perioperative treatment

Preoperative Crystalloid isotonic solutions and antibiotic prophylaxis 30 min prior to surgery. 1\) Patient oral informing. No brochure Surgery Cholecystectomy using monopolar by experienced surgeons under general anesthesia 1. Standard CO2 pressure (12-14 mmHg) 2. No additional anesthesia Postoperative care 1. Mobilization in 4-6 h after surgery 2. Fluid intake in 6 hours 3. Liquid food intake in 12 hours Antibiotics for 3-5 d for patients with complicated cholecystitis (TG13 2). The postoperative pain level evaluation in rest by VAS in 0 h (immediately after awakening), 6 h and 24 h postop. The postoperative analgesic modality on demand: Ketorolac 30 mg for patients with VAS pain level ≥ 5 cm. Antiemetics in dyspepsia. No iv infusions postoperatively. Intestinal peristalsis evaluation by auscultation every 2 h after surgery

Sponsors

Pirogov Russian National Research Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Grade I and II acute cholecystitis according to Tokyo Guidelines 2013 classification (TG13) * ASA I and II.

Exclusion criteria

* Severe acute cholecystitis (Grade III on TG13); * Patient's refusal to participate; * The language barrier; * Transfer to the intensive care unit after surgery; * ASA class ≥ III; * Conversion to open procedure; * Biliary hypertension detected during preoperative examination or intraoperatively.

Design outcomes

Primary

MeasureTime frameDescription
Postoperative length of stay (pLOS)30 daysTime interval measured from the end of the surgery until the moment of discharge from the hospital, measured in days

Secondary

MeasureTime frameDescription
Complication rate30 daysNumber of patients who develop postoperative complications (surgical site infections, intraabdominal organ-specific infection, postoperative ileus) in relation to the total number of patients, measured in percentage
Readmission rate30 daysNumber of patients with readmission to the hospital after discharge in relation to the total number of patients, measured as a percentage
Postoperative pain24 hoursLevel of postoperative pain syndrome measured with a visual analog scale in centimeters
Shoulder pain incidence24 hoursQuantity of patients who developed shoulder pain after surgery in relation to the total number of patients, measured as a percentage
Shoulder pain level24 hoursLevel of shoulder pain syndrome measured with a visual analog scale in centimeters

Countries

Russia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026